Investment Banking

Eason Hahm Quoted in Reuters

William Blair biotech investment banking director Eason Hahm was quoted in a Reuters story centered on biotech M&A activity in 2026.

“Over $300 billion of revenue in the sector faces LOEs in the next five years,” Hahm told the publication.

Our Latest News

Monday, August 10, 2026

Monaco Enterprises Has Been Acquired by Perimeter Solutions

William Blair acted as the exclusive financial advisor to Monaco Enterprises, Inc., a portfolio company of Dauntless Capital Partners and Lometa Capital Partners, in connection with its sale to Perimeter Solutions, Inc. (NYSE: PRM).
Read more
Thursday, August 6, 2026

NavVis Raises Series D Round Led by The Jordan Company

William Blair acted as the sole and exclusive financial advisor to NavVis as it secures a $85M investment round, led by U.S. private equity firm The Jordan Company, as well as existing shareholders Yttrium (together with a consortium of industrial Family Offices), KOZO KEIKAKU ENGINEERING Inc., and Cipio Partners.
Read more
Thursday, July 30, 2026

Glass Half Full—Leveraged Finance Markets Stabilize in Second Quarter Capping a Resilient First Half

Despite macro and geopolitical headwinds, leveraged finance markets stabilized in Q2, setting the stage for stronger M&A activity.
Read more

See more news

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures